Nature Search

Publisher Correction: Ultraviolet radiation–induced DNA damage is prognostic for outcome in melanoma

Lucas D. Trucco
Piyushkumar A. Mundra
Richard Marais
Amendments and Corrections18 Dec 2018
Nature Medicine

Volume: 25, P: 350
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Turajlic and colleagues assess longitudinal antibody and cellular immune responses against SARS-CoV-2 variants of concern in patients with cancer, following either recovery from SARS-CoV-2 infection or vaccination, in two back-to-back reports from the CAPTURE study.

Annika Fendler
Scott T. C. Shepherd
Samra Turajlic
ResearchOpen Access27 Oct 2021
Nature Cancer

Volume: 2, P: 1305-1320
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Turajlic and colleagues assess longitudinal antibody and cellular immune responses against SARS-CoV-2 variants of concern in patients with cancer, following either recovery from SARS-CoV-2 infection or vaccination, in two back-to-back reports from the CAPTURE study.

Annika Fendler
Lewis Au
Samra Turajlic
ResearchOpen Access27 Oct 2021
Nature Cancer

Volume: 2, P: 1321-1337
Correction: Corrigendum: Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53

Amaya Viros
Berta Sanchez-Laorden
Richard Marais
Amendments and Corrections21 Jan 2015
Nature

Volume: 519, P: 118
Ultraviolet radiation–induced DNA damage is prognostic for outcome in melanoma

Mutational signatures in melanoma are associated with prognostic features in patients and suggest distinct disease etiologies associated with the influence of different wavelengths of ultraviolet radiation.

Lucas D. Trucco
Piyushkumar A. Mundra
Richard Marais
Research03 Dec 2018
Nature Medicine

Volume: 25, P: 221-224
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma

Identification of clinical relevant biomarkers to predict response to immune checkpoint blockade (ICB) in melanoma remains challenging. Here, the authors show that stroma remodelling and reduced cell division are associated with durable response to anti-PD1 in a mouse model of melanoma and in ICB-treated patients.

Elena Galvani
Piyushkumar A. Mundra
Richard Marais
ResearchOpen Access12 Feb 2020
Nature Communications

Volume: 11, P: 1-9
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2

A rare case of cytokine release syndrome in a patient on anti-PD-1 blockade that was likely related to BNT162b2 vaccination supports prospective monitoring of patients with cancer after COVID-19 vaccine administration.

Lewis Au
Annika Fendler
Samra Turajlic
ResearchOpen Access26 May 2021
Nature Medicine

Volume: 27, P: 1362-1366
Characterization of a novel transgenic mouse model to investigate brain-wide activation of astrocyte Gq signaling

This study uses a transgenic mouse line expressing Cre-inducible astro-hM3Dq to study astrocytes’ role in neuroinflammation and cognition without the use of viral transduction, mitigating the potential side effects associated with standard techniques.

Alycia M. Crooks
Kate M. Onuska
Marco A. M. Prado
Research24 Jul 2025
Lab Animal

Volume: 54, P: 207-217
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53

Exposing mice with the BRAF (V600E) mutation to levels of ultraviolet radiation that mimic mild sunburn in humans is shown to induce mutations in the tumour suppressor Trp53 (TP53 in humans), accelerating the development of melanoma; these results support the use of sunscreen in individuals at risk of this cancer.

Amaya Viros
Berta Sanchez-Laorden
Richard Marais
Research11 Jun 2014
Nature

Volume: 511, P: 478-482
Predicting opioid consumption after surgical discharge: a multinational derivation and validation study using a foundation model

Chris Varghese
Luke Peters
Caroline Reinke
ResearchOpen Access26 Aug 2025
npj Digital Medicine

Volume: 8, P: 1-16
RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation

Hong Tri Tran
Tobias Kratina
Najoua Lalaoui
ResearchOpen Access21 Mar 2024
Cell Death & Differentiation

Volume: 31, P: 662-671
Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Rajiv V. Dave
Baek Kim
Zaid Al-Ishaq
ResearchOpen Access25 Mar 2021
British Journal of Cancer

Volume: 124, P: 1785-1794
Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial

Swee-Ling Toh
Bonsan Bonne Lee
George Kotsiou
ResearchOpen Access27 Feb 2019
Spinal Cord

Volume: 57, P: 550-561
The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study

Rachel L O’Connell
Tim Rattay
Mohammed Mustafa
ResearchOpen Access29 Mar 2019
British Journal of Cancer

Volume: 120, P: 883-895
A microcosting and cost–consequence analysis of clinical genomic testing strategies in autism spectrum disorder

Kate Tsiplova
Richard M Zur
Wendy J Ungar
Research04 May 2017
Genetics in Medicine

Volume: 19, P: 1268-1275

Search

Filter By:

Search

Quick links